# HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

> **NCT03886688** · PHASE1 · COMPLETED · sponsor: **Sunshine Lake Pharma Co., Ltd.** · enrollment: 116 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HEC53856
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03886688
- **Lead sponsor:** Sunshine Lake Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-14
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2023-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03886688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03886688, "HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03886688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*